Mesa Laboratories, Inc. (MLAB) Stock Analysis
A live, multi-source view of Mesa Laboratories, Inc. (MLAB): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research.
Sector: Technology · Industry: Scientific & Technical Instruments · United States · 717 employees · mesalabs.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Mesa Laboratories, Inc. (MLAB) had a market capitalization of $715.0M, a trailing P/E of 150.3 (forward 12.4), a dividend yield of 0.50% and a beta of 0.96; the shares traded in a 52-week range of $58.83 – $132.70 (100.4% over the year).
- Market cap
- $715.0M
- Enterprise value
- $844.2M
- Trailing P/E
- 150.3
- Forward P/E
- 12.4
- Price / book
- 3.79
- EPS (trailing)
- $0.85
- EPS (forward)
- $10.27
- Dividend yield
- 0.50%
- Payout ratio
- 75.3%
- Ex-dividend date
- 2026-08-31
- 52-week range
- $58.83 – $132.70
- 52-week change
- 100.4%
- Beta
- 0.96
- Average volume
- 189,566
- Shares outstanding
- 5.6M
- Short % of float
- 8.74%
- Profit margin
- 1.9%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-10
In RapidTradeView’s 2026-09-10 scan of the US universe, Mesa Laboratories, Inc. (MLAB) last closed at $123.91 (the last completed close before that scan).
Technicals at the scan: RSI 58 (neutral territory), price +1.7% versus its 20-day average, 20-day versus 50-day average spread +12.3%, MACD histogram -0.67.
Next scheduled company event: in 5 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of MLAB; corporate insiders filed 2 buys and 1 sell (3 distinct filers, latest disclosure 2026-08-17). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: R Tony Tripeny (1B/0S), John James Sullivan (0B/1S), Siddhartha Kadia (1B/0S). Who is trading what
RapidTradeView pick record
MLAB has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Mesa Laboratories, Inc. (MLAB) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell MLAB.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.